ELAVL1 and pulmonary fibrosis: In the present study, we further investigated the anti-pulmonary fibrosis and mechanism of DME targeting lncIAPF–HuR complex in TGFβ1-stimulated lung fibroblast and bleomycin (BLM)-treated mice.